Featured

‘Covaxin Booster Generates Robust Neutralizing Antibodies Against Both Omicron & Delta Variants Of COVID-19’

By
OB Bureau

Bhubaneswar: The booster dose of Covaxin has shown to “neutralize” both Omicron and Delta variants of COVID-19, Bharat Biotech said in a statement on Wednesday.

A booster dose of candidate vaccine generated robust neutralizing antibody responses against both Omicron (B.1.529) and Delta (B.1.617.2) using a live virus neutralization assay, the company said.

It further said that 100% of test serum samples showed neutralization of the Delta variant and more than 90% of serum samples showed neutralization of the Omicron variant.

These data add to the body of evidence that the broad-spectrum mechanism of action of a whole virus inactivated COVID-19 vaccine, like Covaxin, is a viable option in this continuously evolving pandemic, it added.

These were the findings of a study conducted at Emory University in Atlanta (US) demonstrating that sera from subjects who received a booster dose six months after getting a primary two-dose series of Covaxin. The immune sera were analyzed from 13 trial participants, 28 days after their booster jabs. More than 90% of all individuals boosted with Covaxin showed neutralizing antibodies. The neutralization activity of Covaxin boosted sera was comparable to what has been observed in mRNA vaccine-boosted sera against the Omicron variant.

“Data from this preliminary analysis show individuals receiving a booster dose of Covaxin have a significant immune response to both the Omicron and Delta variants. These findings suggest that a booster dose has the potential to reduce disease severity and hospitalization,” said Mehul Suthar, assistant professor, Emory Vaccine Center,  who led the laboratory analysis.

The study was sponsored by Ocugen, Inc., and Ocugen’s partner, Bharat Biotech, provided the sera of the subjects from the Phase 2 study.

“The positive neutralization responses against the Omicron and Delta variants validate our hypothesis of a multi-epitope vaccine generating both humoral and cell-mediated immune responses,” Krishna Ella, CMD of the Hyderabad-based company, was quoted as saying by TNIE.

The findings from the ongoing trial will be published on the pre-print server, medRXiv, in the coming days.

OB Bureau

Recent Posts

Well Marked Low Pressure Over Bay Of Bengal Becomes Depression; Will It Intensify Into Cyclone?

Bhubaneswar: The well-marked low pressure over the Bay of Bengal has intensified into a depression,…

November 25, 2024

Haven’t Resigned From Maharashtra Congress Chief Post, Says Nana Patole Amid Reports Of Stepping Down In Media

Mumbai: Maharashtra Congress chief Nana Patole on Monday reportedly denied media reports claiming that he…

November 25, 2024

Plaint Against SP MP, Four Dead, Prohibitory Orders: Here’s All About The Sambhal Violence Over A Mughal-Era UP Mosque

Bareilly: A day after clashes erupted during the survey of a local mosque following a…

November 25, 2024

IMD Predicts Rise In Night Temp By 2-4°C In Odisha Tomorrow; Rain From Nov 28

Bhubaneswar: Several parts of Odisha are likely to experience light to moderate rain for four…

November 25, 2024

‘Maha’ Politics: Did Ajit Pawar Support Devendra Fadnavis’ Candidature For Maharashtra CM Post?

Mumbai: After the landslide victory of the Mahayuti alliance, the Nationalist Congress Party (NCP) president…

November 25, 2024

Odisha MLA Purna Chandra Sethy’s Vehicle Hits Autorickshaw; 4 Injured

Berhampur: Four persons were injured after the vehicle carrying Odisha MLA Purna Chandra Sethy hit…

November 25, 2024

Odisha Govt To Engage ‘Bank Mitras’ To Resolve Suhbadra Scheme Issues

Bhubaneswar: The Odisha government is set to engage ‘bank mitras’ to resolve problems faced by…

November 25, 2024

SC Junks Pleas Challenging Addition Of Words ‘Socialist’, ‘Secular’ To Preamble To The Constitution, Here’s What CJI Said

New Delhi: The Supreme Court on Monday (Nov 25) dismissed petitions challenging the inclusion of…

November 25, 2024